Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 22

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 22
---
 by the SEC, NASDAQ or FINRA and there not having been                        
 imposed any suspension of, or restriction on, accepting additional deposits of common stock by The Depository Trust Company; |

| · | no condition, occurrence, state of facts or event constituting a Material Adverse Effect (as defined in 
 the Purchase Agreement) shall have occurred and be continuing;                                          |

| · | customary compliance with laws and bankruptcy-related conditions; and |

| · | the receipt by the Selling Shareholder of customary legal opinions, as required under the Purchase Agreement. |

Termination of the Purchase Agreement

Unless earlier terminated
as provided in the Purchase Agreement, the Purchase Agreement will terminate automatically on the earliest to occur of:

| · | the first day of the month next following the 36-month anniversary of the Commencement Date; |

| · | the date on which the Selling Shareholder shall have purchased the Commitment Amount; |

| · | the 90th day after the date on which, pursuant to or within the meaning of any bankruptcy law, we commence                            
 a voluntary case or any person commences a proceeding against us, in each case that is not discharged or dismissed prior to such 90th 
 day; and                                                                                                                              |

| · | the date on which, pursuant to or within the meaning of any bankruptcy law, a custodian is appointed for              
 us or for all or substantially all of our property, or we make a general assignment for the benefit of our creditors. |

We have the right to terminate
the Purchase Agreement at any time after Commencement Date, at no cost or penalty, upon one business day’s prior written notice
to the Selling Shareholder, subject to us satisfying all existing obligations related to any Depositary Shares issued to the Selling Shareholder
prior to the date of termination. We or the Selling Shareholder may also terminate the Purchase Agreement at the close of business on
the one year anniversary of the signing of the Purchase Agreement or thereafter, in the event the Commencement Date shall not have occurred
prior to such one year anniversary due to our failure to satisfy the conditions precedent to commencement. We and the Selling Shareholder
may also terminate the Purchase Agreement at any time by mutual written consent. No termination of the Purchase Agreement by us or by
the Selling Shareholder will affect any of our respective rights and obligations under (i) the Purchase Agreement with respect to any
pending Purchase, and both we and the Selling Shareholder have agreed to complete our respective obligations with respect to any